CJC-1295 without DAC, often referred to as Modified GRF (1-29), is a synthetic GHRH analogue supplied for peptide-signalling research. Laboratory studies commonly examine receptor-interaction behaviour, modified peptide sequence properties and growth hormone-releasing hormone analogue chemistry.
CJC-1295 without DAC, often referred to as Modified GRF (1-29), is a synthetic GHRH analogue supplied for peptide-signalling research. Laboratory studies commonly examine receptor-interaction behaviour, modified peptide sequence properties and growth hormone-releasing hormone analogue chemistry. It is supplied strictly as a high-purity research compound.
The following information is provided for research-catalogue and product specification purposes only. Batch-specific identity, purity, salt form and analytical values should be confirmed against the relevant Certificate of Analysis.
| What it is | CJC-1295 without DAC, often referred to as Modified GRF (1-29), is a synthetic GHRH analogue supplied for peptide-signalling research. Laboratory studies commonly examine receptor-interaction behaviour, modified peptide sequence properties and growth hormone-releasing hormone analogue chemistry. It is supplied strictly as a high-purity research compound. |
|---|---|
| Sequence | H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| Molecular weight | 3367.9 g/mol |
| Product family | GHRH analogue peptide |
| Research classification | Synthetic GHRH (1-29) analogue; endocrine peptide-signalling research compound |
| Form | Lyophilised powder |
| Appearance | White to off-white powder |
| Fill quantity | 5mg |
| Container type | Sterile sealed glass vial |
| Storage | Store dry, protected from light at -20°C. Avoid repeated freeze/thaw cycles after reconstitution. |
| Synonyms | Modified GRF (1-29); CJC-1295 no DAC; tetrasubstituted GRF (1-29) |
| CAS number | 446036-97-1; also listed by some suppliers as 863288-34-0 |
| Molecular form / formula | C152H252N44O42 |
| Molecule form | Amidated synthetic peptide; salt form COA-specific |
| Purity | Recommended product standard: >=98% by HPLC; confirm by batch COA |
| Analysis method | HPLC and LC-MS / MS confirmation |
Each compound is accompanied by third-party analytical documentation where available. Certificates confirm purity, identity and chromatographic analysis against the supplied batch.
Orders are typically processed within 1–2 business days of confirmed payment. Estimated delivery is 10–21 business days after dispatch, depending on destination and courier coverage. All shipping is tracked and discreetly packaged.
Store dry, protected from light at -20°C. Avoid repeated freeze/thaw cycles after reconstitution.
| Form | Lyophilised powder |
|---|---|
| Appearance | White to off-white powder |
| Container type | Sterile sealed glass vial |
| Storage & Handling | Store dry, protected from light at -20°C. Avoid repeated freeze/thaw cycles after reconstitution. |
All products are supplied by Greek Peptides for research use only. They are not licensed as pharmaceuticals and are not promoted as, or intended to diagnose, treat, cure, prevent or mitigate any disease or medical condition in humans or animals. They are not intended for human or animal consumption and are not intended for cosmetic, nutritional or recreational use.
By purchasing, the purchaser confirms that they are a qualified individual acting for legitimate research purposes only and accepts our Terms and Conditions and Research Use Policy.
